Skip to main content
Equibles

CLGN · CollPlant Biotechnologies Ltd · Earnings Call Transcripts & Audio

Track CLGN — free

Use CLGN with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CLGN.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.56 +0.40 (+9.62%) At close · Sep 18
Rebalance outlook locked
Market Cap
$6.60M
Shares
1.89M

CollPlant Biotechnologies Ltd Earnings Call Transcripts

Quarterly earnings calls for CollPlant Biotechnologies Ltd (CLGN), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲15330.3% $10.18M $5.76M '23 Q2 23-06-30 LATEST ▼97.6% $249,000 −$4.21M '24 Q2 24-06-30
Earnings call
FY24 · Q3
2024-09-30
CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Transcript
Positive tone Regenerative breast implant preclinical study Business development and partnerships rhCollagen platform / technology
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
CollPlant Biotechnologies Ltd (CLGN) Q2 2024 Earnings Call Transcript
Confident tone AbbVie dermal filler partnership Regenerative breast implant program rhCollagen and bioink platform
Revenue
$249,000
▼ 97.6% YoY
Diluted EPS
$3.70
▼ 24.5% YoY
Gross margin
-115.3%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
CollPlant Biotechnologies Ltd (CLGN) Q1 2024 Earnings Call Transcript
Positive tone AbbVie Dermal Filler Partnership Regenerative Breast Implants FDA Regulatory Pathway
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
CollPlant Biotechnologies Ltd (CLGN) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
CollPlant Biotechnologies Ltd (CLGN) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
CollPlant Biotechnologies Ltd (CLGN) Q2 2023 Earnings Call Transcript
Revenue
$10.18M
▲ 15330.3% YoY
Diluted EPS
$4.90
Gross margin
94.0%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
CollPlant Biotechnologies Ltd (CLGN) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
CollPlant Biotechnologies Ltd (CLGN) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–8 of 8 earnings calls
Key facts CIK 1631487 CUSIP M2R51X116 13F (30d) 1 filings 1 filers Visit website Investor relations